全文获取类型
收费全文 | 4040篇 |
免费 | 287篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 37篇 |
妇产科学 | 59篇 |
基础医学 | 550篇 |
口腔科学 | 34篇 |
临床医学 | 454篇 |
内科学 | 1334篇 |
皮肤病学 | 23篇 |
神经病学 | 365篇 |
特种医学 | 136篇 |
外科学 | 491篇 |
综合类 | 26篇 |
一般理论 | 6篇 |
预防医学 | 185篇 |
眼科学 | 42篇 |
药学 | 243篇 |
中国医学 | 10篇 |
肿瘤学 | 346篇 |
出版年
2024年 | 3篇 |
2023年 | 26篇 |
2022年 | 43篇 |
2021年 | 105篇 |
2020年 | 59篇 |
2019年 | 105篇 |
2018年 | 124篇 |
2017年 | 93篇 |
2016年 | 84篇 |
2015年 | 119篇 |
2014年 | 172篇 |
2013年 | 230篇 |
2012年 | 310篇 |
2011年 | 338篇 |
2010年 | 193篇 |
2009年 | 148篇 |
2008年 | 287篇 |
2007年 | 271篇 |
2006年 | 248篇 |
2005年 | 264篇 |
2004年 | 221篇 |
2003年 | 215篇 |
2002年 | 183篇 |
2001年 | 78篇 |
2000年 | 65篇 |
1999年 | 75篇 |
1998年 | 37篇 |
1997年 | 31篇 |
1996年 | 30篇 |
1995年 | 12篇 |
1994年 | 15篇 |
1993年 | 12篇 |
1992年 | 16篇 |
1991年 | 17篇 |
1990年 | 21篇 |
1989年 | 10篇 |
1988年 | 18篇 |
1987年 | 19篇 |
1986年 | 10篇 |
1985年 | 7篇 |
1983年 | 3篇 |
1981年 | 2篇 |
1980年 | 5篇 |
1979年 | 3篇 |
1976年 | 3篇 |
1975年 | 3篇 |
1972年 | 2篇 |
1971年 | 2篇 |
1969年 | 3篇 |
1967年 | 3篇 |
排序方式: 共有4350条查询结果,搜索用时 15 毫秒
81.
During recent years, molecular techniques have significantly impacted our understanding and therapeutic concepts in gastrointestinal and liver disease. In a number of diseases, diagnostic work-up includes molecular data that supplements the phenotypical evaluation. This includes monogenic diseases as well as the identification of genetic risk factors (e. g. NOD2/CARD15 mutation in Crohn's disease) and viral disease. Attempts to replace liver transplantation in hereditary liver disease by targeted molecular interventions (e. g. via viral vectors) are still experimental, but the associated techniques have improved considerably. The molecular identification of therapeutic targets was followed by the development of specifically tailored therapeutics. These agents are mainly used in the treatment of chronic inflammatory bowel disease and gastrointestinal tumors. 相似文献
82.
M. Rizzetto K. Grotzinger D. Theodore D. Demuth W. L. Irving M. Manns A. Roughley U. M. Forssen 《Journal of viral hepatitis》2014,21(10):e129-e134
Antiviral therapy has been shown to reduce the risk of disease progression, liver damage and death in patients with chronic hepatitis C virus (HCV) infection. While interferon labels recommend that patients with platelet counts below 50 × 103/μL not receive interferon‐based therapy, it is unknown to what extent thrombocytopaenia influences treatment decisions in practice. This study profiles the reasons for withholding antiviral treatment in HCV patients with thrombocytopaenia in five European countries. Medical records of 466 patients who had HCV infection and thrombocytopaenia (platelet count <100 × 103/μL) in 2006 were retrospectively reviewed for clinical characteristics. Collected data included use of antiviral therapy and reasons for withholding therapy. In total 184 of 466 patients (39.5%) did not receive interferon‐based therapy during the study period, with treatment withheld most frequently due to multiple clinical characteristics including hepatic cirrhosis (16.3%), thrombocytopaenia (16.3%) and age >60 years (10.9%). The reasons for lack of treatment varied among countries, with thrombocytopaenia as a reason being more common in Italy (10.9%) and Spain (20.0%), and less common in France, Germany and the UK (3.2–7.1%). Overall, thrombocytopaenia was reported as the only reason for withholding treatment in 4.9% of untreated patients. This study demonstrates that thrombocytopaenia is one of many factors, indicative of the poor clinical state of the patient, that contributes to withholding antiviral treatment. In 4.9% of untreated patients, thrombocytopaenia can be considered as a modifiable factor to enable more HCV patients to receive guideline‐recommended therapy and thus improved clinical outcomes. 相似文献
83.
84.
Cdric Farges Olivier Cointault Marlne Murris Laurence Lavayssiere Shrazade Lakhdar‐Ghazal Arnaud Del Bello Anne‐Laure Hebral Laure Esposito Marie‐Batrice Nogier Federico Sallusto Xavier Iriart Elena Charpentier Joelle Guitard Fabrice Muscari Camille Dambrin Lydie Porte Nassim Kamar Sophie Cassaing Stanislas Faguer 《Transplant infectious disease》2020,22(1)
85.
86.
87.
Martine Gavaret Jean-Michel Badier Fabrice Bartolomei Christian-Georges Bénar Patrick Chauvel 《Brain topography》2014,27(1):192-196
Interictal or ictal events in partial epilepsies may project on scalp EEG contralaterally to the side of the epileptogenic lesion. Such paradoxical lateralization can be observed in case of para-sagittal generators, and is likely due to the spatial orientation of the generator, presenting an oblique projection towards the midline. We present here a case of medial occipital epilepsy investigated using EEG, MEG and stereoelectroencephalography (SEEG). MRI displayed a focal cortical dysplasia in the superior margin of the right calcarine fissure. SEEG demonstrated bilateral medial occipital interictal spikes, with an inversion of polarity at the level of the lesion and a contralateral propagation occurring in 10 ms. Interictal iterative EEG cartographies showed a large posterior field, with a maximum contralateral to the initial generator (EEG paradoxical lateralization). With the same number of channels, interictal iterative MEG cartographies were more precise and more complex than EEG ones, indicating an onset accurately lateralized. A few milliseconds later, MEG cartographies were quadripolar, thus indicating two homotopic active generators. These MEG and EEG cartographies have been reproduced using BESA dipole simulator. Relative merits of MEG and EEG are still debated. With 151 channels, MEG source localizations indicated the right medial occipital area, as demonstrated by SEEG. An investigation with a corresponding number of EEG channels was not performed. After a down sampling to 64 sensors, this precision was lost. MEG and EEG source localization results, both with 64 channels, were quite comparable, indicating both medial occipital areas. However, a careful analysis of MEG/EEG iterative cartographies, performed with the same number of channels in both modalities, demonstrated that, in this configuration, MEG sensitivity was superior to the EEG one, allowing separating two medial occipital sources, characterized in SEEG by a time delay of 10 ms. 相似文献
88.
89.
Anna Kallio Kirsi Sepponen Philippe Hermand Philippe Deno?l Fabrice Godfroid Merit Melin 《Infection and immunity》2014,82(4):1683-1691
Pneumococcal adherence to mucosal surfaces is a critical step in nasopharyngeal colonization, but so far few pneumococcal adhesins involved in the interaction with host cells have been identified. PhtA, PhtB, PhtD, and PhtE are conserved pneumococcal surface proteins that have proven promising as vaccine candidates. One suggested virulence function of Pht proteins is to mediate adherence at the respiratory mucosa. In this study, we assessed the role of Pht proteins in pneumococcal binding to respiratory epithelial cells. Pneumococci were incubated with human nasopharyngeal epithelial cells (Detroit-562) and lung epithelial cells (A549 and NCI-H292), and the proportion of bound bacteria was measured by plating viable counts. Strains R36A (unencapsulated), D39 (serotype 2), 43 (serotype 3), 4-CDC (serotype 4), and 2737 (serotype 19F) with one or more of the four homologous Pht proteins deleted were compared with their wild-type counterparts. Also, the effect of anti-PhtD antibodies on the adherence of strain 2737 to the respiratory epithelial cells was studied. Our results suggest that Pht proteins play a role in pneumococcal adhesion to the respiratory epithelium. We also found that antibody to PhtD is able to inhibit bacterial attachment to the cells, suggesting that antibodies against PhtD present at mucosal surfaces might protect from pneumococcal attachment and subsequent colonization. However, the relative significance of Pht proteins to the ability of pneumococci to bind in vitro to epithelial cells depends on the genetic background and the capsular serotype of the strain. 相似文献
90.
Complex karyotype in mantle cell lymphoma is a strong prognostic factor for the time to treatment and overall survival,independent of the MCL international prognostic index 下载免费PDF全文
Fabrice Jardin Isabelle Radford Catherine Roche‐Lestienne Dominique Penther Christian Bastard Sophie Rigaudeau Sylvain Pilorge Franck Morschhauser Didier Bouscary Richard Delarue Hassan Farhat Philippe Rousselot Olivier Hermine Hervé Tilly Sylvie Chevret Sylvie Castaigne 《Genes, chromosomes & cancer》2014,53(1):106-116
Mantle cell lymphoma (MCL) is usually an aggressive disease. However, a few patients do have an “indolent” evolution (iMCL) defined by a long survival time without intensive therapy. Many studies highlight the prognostic role of additional genetic abnormalities, but these abnormalities are not routinely tested for and do not yet influence the treatment decision. We aimed to evaluate the prognostic impact of these additional abnormalities detected by conventional cytogenetic testing, as well as their relationships with the clinical characteristics and their value in identifying iMCL. All consecutive MCL cases diagnosed between 1995 and 2011 at four institutions were retrospectively selected on the basis of an informative karyotype with a t(11;14) translocation at the time of diagnosis. A total of 125 patients were included and followed for an actual median time of 35 months. The median overall survival (OS) and survival without treatment (TFS) were 73.7 and 1.3 months, respectively. In multivariable Cox models, a high mantle cell lymphoma international prognostic index score, a complex karyotype, and blastoid morphology were independently associated with a shortened OS. Spleen enlargement, nodal presentation, extra‐hematological involvement, and complex karyotypes were associated with shorter TFS. A score based on these factors allowed for the identification of “indolent” patients (median TFS 107 months) from other patients (median TFS: 1 month). In conclusion, in this multicentric cohort of MCL patients, a complex karyotype was associated with a shorter survival time and allowed for the identification of iMCL at the time of diagnosis. © 2013 Wiley Periodicals, Inc. 相似文献